Effects on mortality of early vs late administration of convalescent plasma in the treatment of Covid-19

The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first seen in the city of Wuhan, China, in December 2019 and then spread worldwide. On 24 March 2020, the U.S. Food and Drug Administration reported that the use of convalescent plasma (CP) containing antibodies against...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Transfus Apher Sci
Autori principali: Kocayiğit, Havva, Demir, Gürkan, Karacan, Alper, Süner, Kezban Özmen, Tomak, Yakup, Yaylacı, Selçuk, Dheir, Hamad, Kalpakci, Yasin, Erdem, Ali Fuat
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier Ltd. 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8064905/
https://ncbi.nlm.nih.gov/pubmed/33962885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.transci.2021.103148
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi